Infectious Diseases II
OI/CD4+ Threshold
for Prophylaxis
Prophylaxis Option
Treatment Option
P. jiroveci:
< 200 cells/mm3
and/or CD4 cell
percentage < 14%
Preferred:
TMP/SMXb 1 DS PO
daily
or
TMP/SMXb 1 SS PO daily
Alternatives
Dapsonea PO 100 mg/day
Pentamidine 300 mg
inhalation once monthly
TMP/SMX 1 DS PO TIW
Atovaquone PO 1500 mg/
day
Preferred:
TMP/SMXb 15β20 mg/kg PO/IV divided q6β8hr x 21 days
plus
prednisone 40 mg PO q12hr x 5 days; 40 mg/day x 5 days;
20 mg/day x 11 days
(if Pao2 < 70 mm Hg or alveolar-arterial O2 gradient > 35)
(IV methylprednisolone could be administered at 75% of
the corresponding oral prednisone dose)
Alternatives:
Pentamidineb IV 4 mg/kg/day
Clindamycin 600β900 mg PO/IV q6β8hr + primaquinea PO
30 mg/day (base)
Atovaquone 750 mg PO q12hr β mild disease
Toxoplasmosis:
< 100 cells/mm3
and Toxoplasma IgG
positive
Preferred:
TMP/SMX 1 DS PO daily
Alternatives:
Dapsonea PO 50 mg/day +
(pyrimethamine 50 mg
PO + leucovorin 25 mg
PO) once weekly
TMP/SMX 1 DS PO TIW
Preferred:
Pyrimethamineb 200 mg PO x 1; then 50β75 mg/day +
sulfadiazineb 1000β1500 mg PO q6hr + leucovorin PO
10β20 mg/day x 6 wk
Alternatives:
Pyrimethamineb 200 mg PO x 1; then 50β75 mg/day +
clindamycin 600β900 mg PO/IV q8hr + leucovorin PO
10β20 mg/day
Pyrimethamineb 200 mg PO x 1; then 50β75 mg/day +
atovaquone 1500 mg PO BID + leucovorin PO 10β20 mg/
day
Mycobacterium avium
complex:
< 50 cells/mm3
M avium complex:
< 50 cells/mm3
AND not receiving
antiretroviral therapy
(ART), remain
viremic while treated
with ART, or have
no options for a fully
suppressive ART
regimen
Preferred:
Azithromycin 1200 mg
once weekly
or
Clarithromycin 500 mg
q12hr
or
Azithromycin 600 mg
twice weekly
Alternatives:
Rifabutinc 300 mg/day
Preferred:
At least two drugs: Clarithromycin 500 mg PO BID or
azithromycin 600 mg/day
plus ethambutolb PO 15β25 mg/kg/day
Additional agents (consider depending on susceptibility
testing, severe disease, or low CD4+ count)
Rifabutinc PO 300 mg/day
Amikacinb IV 10β15 mg/kg/day
fluoroquinolones (moxifloxacin PO/IV 400 mg/day or
levofloxacinb PO/IV 500 mg/day)